SunWay Biotech Co (1271.TWO) Stock Price
SunWay Biotech Co Price
Over the last 12 years SunWay Biotech Co grew revenue by 38.1% annually, reaching 993.30 M TWD. Earnings per share have grown at 7.7% per year over the last 6 years. For SunWay Biotech Co, the net margin of 10.2% is down versus 44.4% a few years ago. At today's price the dividend yield works out to roughly 2.26%. The payout ratio is around 79% of earnings.
SunWay Biotech Co stock price
SunWay Biotech Co business model & stock analysis
Frequently asked questions about SunWay Biotech Co
Converted at the current exchange rate, the SunWay Biotech Co share trades at 1.64 EUR (58.80 TWD).
The revenue cannot currently be calculated for SunWay Biotech Co.
The profit cannot currently be calculated for SunWay Biotech Co.
The P/E ratio cannot be calculated for SunWay Biotech Co at the moment.
The P/S cannot be calculated for SunWay Biotech Co currently.
The Eulerpool Quality Score for SunWay Biotech Co is 5/10.
The ISIN of SunWay Biotech Co is TW0001271005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of SunWay Biotech Co is 1271.TWO. The ticker symbol is used to trade SunWay Biotech Co shares on the stock exchange.
SunWay Biotech Co stock
SunWay Biotech Co Peer Group
SunWay Biotech Co FIGI
All fundamentals and in-depth analysis of SunWay Biotech Co
Our stock analysis for SunWay Biotech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SunWay Biotech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.